Just Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Business > PR > Publicity: Nailing a Media Interview, Part III (Staying on Topic)

Tags

  • topic
  • their
  • tackle
  • combination products
  • companies involved

  • Links

  • A Home Party Business Could Be Your Ticket
  • You Need To Know The Possible Hair Loss Causes
  • Know Your Rights When You Apply For a Mortgage
  • Just Other Articles - Publicity: Nailing a Media Interview, Part III (Staying on Topic)

    In a media interview, always stick to your main points without ra
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    mbling or digressing. Practice this when you rehearse.

    Sometimes
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    , when you are doing a great job of keeping on topic, the reporte
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    r is leading to you talk about different topics, some of which yo
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    u aren't as knowledgeable about. If the reporter leads you into d
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ifferent areas, go there only if it suits your needs and you are
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    comfortable there.

    One advanced technique you can use in a tough
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    interview is "bridging." Bridging is simply steering the intervie
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    w back to your topic. Going down any side roads a reporter pursue
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    s is usually a bad idea – even if the detour is innocuous, it tak
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    es you off your main points. You may find, when the article is pu
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    blished or the interview airs, that the only comments of yours th
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    at reach the general public are those about a topic that you don'
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    t know much about. This isn't going to help your marketing effort
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    at all.

    Don’t be afraid to bridge. If the reporter asks, “Well,
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    how do they feel about that in Argentina?” and you have nothing
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    to say about Argentina, diplomatically acknowledge that the quest
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ion is valid. For example, say "That's a good question. I don't f
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ocus on Argentina in my practice, but I can tell you what my clie
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    nts are saying." Then move back to your topic – gently but firmly


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justotherarticles.org.ua/article/33987/justotherarticles-Publicity-Nailing-a-Media-Interview-Part-III-Staying-on-Topic.html">Publicity: Nailing a Media Interview, Part III (Staying on Topic)</a>

    BB link (for phorums):
    [url=http://www.justotherarticles.org.ua/article/33987/justotherarticles-Publicity-Nailing-a-Media-Interview-Part-III-Staying-on-Topic.html]Publicity: Nailing a Media Interview, Part III (Staying on Topic)[/url]

    Related Articles:

    Private Label Drinking Water - A Powerful Brand Builder

    Drop It Like It's Hot Marketing

    Effective Printed Materials Make Great Trade Show Handouts

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com